Search Result "Molnupiravir"
Molnupiravir in COVID-19: A Scoping Review
Journal: Current Drug Research Reviews
Volume: 14 Issue: 3 Year: 2022 Page: 203-214
Author(s):
Safety Profile of Molnupiravir with Significant Effect on COVID-19: AReview
Journal: Current Drug Therapy
Volume: 18 Issue: 3 Year: 2023 Page: 183-193
Author(s): Abhay Kumar Upadhyay,Ravi Pratap Singh
Recent Advances on the Synthesis of Orally Active Antiviral Drug Molnupiravir
Journal: Current Organic Chemistry
Volume: 27 Issue: 20 Year: 2023 Page: 1754-1761
Author(s): Basi V. Subba Reddy
Role of Molnupiravir in the Treatment of COVID-19
Journal: Anti-Infective Agents
Volume: 21 Issue: 4 Year: 2023 Page: 31-40
Author(s): Vaishali M. Patil,Gaurav Pratap Singh
Development and Validation of In-vitro Release Study of MolnupiravirCapsules by RP-HPLC
Journal: Current Pharmaceutical Analysis
Volume: 19 Issue: 7 Year: 2023 Page: 577-585
Author(s): Gaurav Pratap Singh Jadaun,Vaishali M. Patil
State-of-the-art Tools to Elucidate the Therapeutic Potential of TAT-peptide (TP)Conjugated Repurposing Drug Against SARS-CoV-2 Spike Glycoproteins
Journal: Current Pharmaceutical Design
Volume: 28 Issue: 46 Year: 2022 Page: 3706-3719
Author(s): Mohammad Azam Ansari,Mohammad N. Alomary,Qazi Mohammad Sajid Jamal,Suliman A. Almahmoud
Would the Development of a Multitarget Inhibitor of 3CLpro andTMPRSS2 be Promising in the Fight Against SARS-CoV-2?
Journal: Medicinal Chemistry
Volume: 19 Issue: 5 Year: 2023 Page: 405-412
Author(s): Igor José dos Santos Nascimento,Ricardo Olimpio de Moura
Discovery of Novel Cysteine Protease Inhibitors for the Treatment ofCoronavirus (COVID-19)
Journal: Current Medicinal Chemistry
Volume: 31 Issue: 9 Year: 2024 Page: 1165-1169
Author(s): Surya K. De
Promising Repurposed Antiviral Molecules to Combat SARS-CoV-2:A Review
Journal: Current Pharmaceutical Biotechnology
Volume: 24 Issue: 14 Year: 2023 Page: 1727-1739
Author(s): Dinesh Kumar Mishra,Rupesh Kumar Gautam
SARS-CoV-2 Protease Inhibitors of Natural Origin: Current Scenario and Future Prospects as Anti-COVID-19 Agents
Ebook: Frontiers in Drug Design and Discovery
Volume: 12 Year: 2024
Author(s): Naveen Kumar Reddy,A. Srinivasa Rao,D. Geetha Mounika,Katharigatta N. Venugopala,Pran Kishore Deb,M. Raghu Prasad
Doi: 10.2174/9789815165258123120006